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TUMOR VIRUSES
It has been known for many years that infection of an experimental animal
with one of a relatively small group of viruses somehow resulted in the
appearance of gross tumors. Because of this and the known intimate
relationships between the infecting virus and the functions of the cell it
invades, many scientists have hypothesized that cancer in man may well be
of viral etiology. Yet even today when the amount and sophistication of
tumorvirus research has markedly increased in recent years, it is not known
how avirus transforms a normal cell to one having the properties of a tumor
cell nor is there direct evidence that viruses cause cancer in man.
However, in the last five years there has been a remarkable change in
the experimental approach to the study of tumor viruses. Whereas most
early investigations were limited to observations of biological phenomena at
the whole animal-gross tumor level, now modern, virological, biochemical,
and immunological methods are used to examine the quantitative interaction
of tumor viruses with the single cell in the transforming event and to look
for determining characteristics of the tumor virus particles, as such. This
has been a logical development as techniques in these basic areas have been
discovered and applied to other biological problems.
Thus, although the final answers are still far from being achieved, we
find that a number of basic factors of importance in viral oncogenesis have
been defined in certain experimental virus-induced tumor systems.
IMPORTANCE OF IN VITRO SYSTEMS FOR VIRUS TRANSFORMATION
The chief reason that we are able to start formulating some tentative
answers to the question of how a virus transforms a normal cell to a tumor
cell is the development of tissue culture systems in which virus trans-
formation occurs in vitro. The degree of control that these isolated systems
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give the investigator makes it possible to pinpoint events, to reduce the
number of variables influencing a reaction, and to use quantitative methods.
One of the most practical advantages to the in vitro transformation system
over the old method of inoculating animals and observing tumor develop-
ment is the time factor. Answers in some cases can be obtained in a few
days in the tissue culture system when tumor induction in the whole
animal might require months. Furthermore, the oncogenic potential of
a virus can be tested in human cells.
Such in vitro transforming systems have now been demonstrated for
Rous sarcoma' and avian myeloblastosis viruses,2 polyoma,8 SV 40,' and
adenovirus,5 but most of the quantitative studies in tissue cultures have
been with Rous and polyoma viruses. The criteria of in vitro transformation
depend on the increased growth potential of the transformed cell and the
loss of normal contact inhibition between contiguous cells resulting in a
multilayered piling up to produce a dense "focus." The appearance of
chromosomal abnormalities following invasion by the virus may also be
evidence of an oncogenic infection. However, none of these criteria is
absolute and probably the most universally accepted evidence of true
oncogenic transformation in an in vitro system is the ability of the cells to
produce a tumor on inoculation into the proper animal host.
EFFICIENCY OF VIRAL TRANSFORMATION AND IMPORTANCE OF NUCLEIC ACIDS
Even though there has been experimental evidence that viruses can cause
tumors, it has not been known if this was a direct action on the infected
cell or indirect through the formation of some carcinogen-like by-product
of ordinary lytic cell infection. As the result of quantitative in vitro studies
with Rouse and polyoma viruses,7 there is now no doubt that oncogenesis
is a direct effect of the virus infection on the cell it transforms, and a single
virus particle is sufficient. Yet, although only one virus particle is effective
in producing the transformation of one cell, the likelihood that this event
will occur when cells are exposed to heavy doses of virus is relatively small.
In the case of polyoma, one million virus particles must be used to produce
one transforming event, and no matter how much concentrated virus is
inoculated into culture, 10 to 20 per cent is the upper limit of the number
of cells transformed.! It is not known if this inefficiency is due to a low
proportion of active virus particles or to a rare chance among equally
competent particles, but the latter seems more probable. Just as in the case
of ordinary viruses causing lytic infection, the characteristics of tumor
viruses, including their ability to transform cells, are determined by the
genetic code residing in their nucleic acid cores. It has been shown that
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the purified extracted viral DNA of polyoma,8 SV 409 and Shope papilloma
viruses,'0 and RNA of mouse leukemia virus" is capable of producing
tumors in the absence of viral proteins or other constituent materials.
Polyoma DNA is capable of causing transformation of tissue culture cells
and one molecule of DNA is effective. Yet, as in the case of whole polyoma
virus, the efficiency is low since 108 or 109 DNA molecules are required
for one transforming event.'
WHAT DETERMINES THE ONCOGENIC PROPERTIES OF A TUMOR VIRUS?
The range of general physical and chemical characteristics of viruses
capable of causing tumors is just as wide as in viruses causing acute infec-
tions. Tumor viruses may have RNA or DNA as their nucleic acid
genomes, they may be rigid icosahedras with protein coats arranged in
capsomeres or more amorphous with lipid-containing membranes, and
they may vary in size and complexity of structure. In fact, at the present
time we cannot even rule out the possibility that all viruses may have the
inherent possibility of causing tumors under the proper set of circumstances.
It is, therefore, difficult to be sure that we really have nononcogenic viruses
to compare with the known tumor viruses in looking for those charac-
teristics which might determine tumor-inducing properties. Yet it is obvious
that a tumor-inducing virus must be capable of infecting and influencing
a cell without killing it. In fact, the evidence suggests that a limited if not
abortive viral replicative cycle is required for transformation. It appears
that viral influence continues in the transformed cell whether this results in
persistent complete viral replication or the synthesis of only viral genome
integrated with cell genome. The mere presence of persisting viral material
is not enough to explain oncogenesis. Some result of its presence must have
an effect on control of cell metabolism and multiplication. The enzymes
responsible for and possible normal repressors of DNA synthesis in the non-
dividing, controlled, normal cell may be either stimulated or inhibited by
specific biochemical entities called forth and even coded by the viral nucleic
acid.
The question has been raised as to whether the chemical composition of
the nucleic acid of tumor viruses differs in some uniform way from that of
nontumor viruses. Although this is undoubtedly true, the evidence to date is
limited and nonconclusive. The guanine plus cytosine ratio of base composi-
tion of the DNA of oncogenic adenoviruses was found to be lower and
closer to that of the DNA of mammalian cells in oncogenic adenoviruses
types 12 and 18 than in apparently nononcogenic types 2 and 4.13 However,
when adenovirus 7 was found to be oncogenic, its base composition was
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intermediate in its GC ratio.' Since the amount of the various bases in DNA
does not reflect their sequence in the molecule, evidence has been sought for
similarity of base sequence in oncogenic versus nononcogenic adenovirus
DNA's. Again adenoviruses 12 and 18 had a high level of similarity in
base sequence compared to types 2 and 4 but adenovirus 7 had little simi-
larity with types 12 and 18.& If, in the case of DNA tumor viruses, actual
integration into the DNA of the cell is required for transformation, then
there may have to be base sequence similarities between the viral and
normal cellular DNA's. Some suggestive evidence for this has been obtained
in preliminary experiments with polyoma DNA when tested for "homoiogy"
with DNA of normal mouse, hamster, and even human cells.'
TABLE 1. PROPERTIES OF RNA AND DNA TUMOR VIRUSES
RNA tumor vsrus DNA tumor zirus
Virus production and transformation Virus production or transformation
Virus matures by budding at cell membrane Virus matures in nucleus
Amorphous, myxovirus-like Icosahedral with capsomeres
Infectious virus in tumor Infectious virus usually not in tumor
No definite lytic infectious cycle Multiplies with lysis in some cells
Finally, in considering what determines oncogenicity of a given virus we
must remember that the cell itself may exert a strong determining influence.
When polyoma virus is inoculated into mouse embryo tissue cultures most
cells go through a lytic cycle of virus multiplication, but a few survive and
are transformed.'7 This happens even if the culture has been cloned and,
therefore, all cells theoretically are the same. This suggests that the genetic
potential of the virus may be influenced by the physiological state of the
infected cell and that the conditions prevailing at the time of interaction of
the virus genome with the cell may be a determinant in transformation.
RELATIONSHIP OF VIRUS TO THE CELL IT HAS TRANSFORMED
All known tumor viruses can multiply and produce more infective virus
particles just as do ordinary viruses. DNA tumor viruses such as polyoma
and RNA viruses such as the avian leukoses differ, however, in their
relationships to the infected transformed cell (Table 1).
DNA viruses can either multiply and kill the cell in the process of
making more infectious virus or transform the cell without subsequent virus
production. Usually virus production and transformation do not take place
in the same cell.'8 Yet these two states are not mutually exclusive since
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virus production with lysis of the cell may occur when polyoma transformed
cells are superinfected with polyoma virus."9 There may well be a common
pathway following infection of a cell with a DNA tumor virus involving
synthesis of messenger RNA coded for by the DNA of the infecting virus.
Subsequently there might be a choice of pathways-expression of all the
viral genes with production of complete infective virus or limited gene
expression with transformation and a lack of synthesis of viral protein coat
and assembly of fully infectious particles. It may be assumed, therefore,
in the case of transformation, that viral function is limited either through
repression of gene function or through physical defect in the viral genetic
material. The molecular weight of the DNA of the small tumor viruses,
such as polyoma, is capable of coding for 5 to 10 average size proteins.
Since the total number of genes is small, it may eventually be possible to
determine which are expressed or suppressed in the limited viral cycle in
a transformed cell. The fact that animal tumors induced by DNA tumor
viruses frequently are free of demonstrable infectious virus keeps us from
being discouraged over the negative findings with human tumors. Recent
studies have indicated several possible means of demonstrating the hidden
or masked DNA tumor virus in "virus-free" tumor cells.
First of all the masked virus might be induced to complete its maturation
and appear as whole infectious virus similar to the well known induction
of temperate bacteriophage in lysogenized bacteria. Thus far, attempts to
induce the virus-free tumor cells have not been too successful. Some evi-
dence suggests it has been accomplished at a very low level of efficiency in
SV 40 virus induced hamster tumor cells2 but extensive attempts in
polyoma tumors have been negative.'8 Quite recently the "marker rescue"
type of experiment appears to have been positive in polyoma cells."
A "virus-free" tumor induced in the mouse by a strain of polyoma virus
having a certain specific genetic characteristic was challenged with a differ-
ent strain of polyoma virus lacking that character. The new virus produced
by this superinfection had the character of the original tumor-inducing
strain.
Direct extraction of viral nucleic acid from the virus-free tumor has been
successful in Shope papillomas of domestic rabbits'0 but negative in other
virus-induced tumors. The small amount of "integrated" viral genome in
the large cell genome and the very low efficiency of demonstrating infectivity
of viral nucleic acids makes this method unlikely to be readily usable.
Recently a different approach has been successful in the polyoma system.
On the assumption that viral DNA is somehow integrated into the cell
DNA of the transformed cell, an attempt was made to demonstrate it
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directly by interacting the purified tumor cell DNA with that from purified
virus. This was done by a technique known as DNA-DNA homology
depending on the demonstrated fact that if single strands of two DNAs
have substantial base sequences in common they will combine to make a
double strand by "zipping up." This can be tested using radioactive
viral DNA. In a virus-free polyoma mouse tumor the degree of homology
was found to be 2Y2 times that with DNA from normal mouse tissue."
Although such an indirect approach may supply means of establishing a
specific etiological relationship between a given virus and a given human
tumor they will not make the demonstration of a new human tumor virus
possible. However, the DNA homology type of experiment has the much-
needed advantage of bringing specificity into testing for etiological relation-
ships.
In the RNA virus-induced tumor cells the situation appears to be quite
different. Here the transformed cell frequently continues to produce infec-
tious virus with survival and multiplication of the cell. The situation as
studied in the Rous virus-chicken embryo cell system is somewhat confused,
since the Bryan strain of Rous virus appears to be defective. If this virus
infects cells, they are transformed; but no infectious virus is produced
unles another related avian leukosis virus is present and acts as a "helper"
virus by supplying the missing protein coat for the Rous viral RNA.'
IMMUNOLOGICAL FACTORS IN VIRAL ONCOGENICITY
Even though viral genetic material as such might not be directly demon-
strable in virus-free transformed cells, it is possible that some virus-specific
"marker" might reflect the continuing expression of an "integrated" viral
genome. Although oncogenic properties in zivo and growth potential, clonal
type, and chromosomal complement of cells in vitro may be such an expres-
sion, these characteristics are not specific to the virus responsible for their
appearance. However, the demonstration of new antigens in the trans-
formed cells has introduced the important element of specificity. At the
present time these antigens fall into two major categories which are based
on the methods used to demonstrate them: 1) a transplantation type of
antigen demonstrated by resistance to challenge with tumor cells,""' and
2) a complement-fixing antigen demonstrated by antibodies developing in
the sera of animals with tumors' (Table 2).
Antigens of one type or the other, and in some instances of both, have
been found in every kind of virus-induced tumor in which they have been
sought. More experimental work on these antigens has been done with
DNA than with RNA virus-induced tumors, but both types of antigen
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have been shown in tumors resulting from infection with RNA and DNA
viruses. They are also present in cells transformed in vitro.
The evidence so far suggests that these antigens are not structural
antigens of the virus particle itself. In tumors such as those induced by
polyomaand SV40viruses, where both the transplantation and complement-
fixing types of antigens are present, the antigens may be different." The
specificity of both types of antigen is related to the inducing virus and
appears to be qualitatively the same in cells of different species transformed
TABLE 2. SUMMARY OF PROPERTIES OF NEW ANTIGENS IN
VIRUS-INDUcED TUMORS
Homograft Serological
Characteristics of antigens type antigen type antigen
Present in virus-induced tumors + +
Present in in zitro transformed cells + +
Present in lytic cell infection ? 4-
Virus specific + +
Present in virus particle
Animal reaction, cell mediated +
Animal reaction by AB in serum - +
Reaction produced by virus inoculation +
Reaction produced by tumor inoculation + +
Involved in viral oncogenesis +
Cross reacting between species + +
by the same virus. Where different but related serological types of viruses
are oncogenic, tumors induced by them may share some complement-
fixing antigens, as is seen in cross-reactions between adenovirus 12 and
adenovirus 18 tumors' and between members of the avian leukosis group
of agents.'
Using antisera produced by tumor-bearing animals, the presence of
reacting antigens has been demonstrated in Gross, Moloney, Rauscher,
Graffi, and Friend mouse leukemia cells by a cytotoxic test.," Antigens have
also been demonstrated by fluorescent staining of SV 40 and adenovirus
tumor' and Rauscher, Graffi, and Moloney leukemia cells.'m
The chemical or physical nature of these antigens is unknown with the
exception of the antigenic new enzyme, arginase, shown to be produced
in Shope virus papillomas.' Because of the nature of the homograft rejec-
tion technique used to demonstrate its presence, it is assumed that the
homotransplantation type antigen is on the surface of the tumor cell. The
CF antigen in SV 40 tumor cells, on the other hand, is seen in the nucleus.
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There is as yet no evidence as to any contribution these antigens may make
to the oncogenic properties of the tumor cell, yet the importance of the
cell surface in such phenomena as contact inhibition, cell division, inter-
cellular exchange of materials and immunological rejection offer interesting
sources of speculation. Even though the new antigens may not be responsi-
ble for oncogenic properties of individual cells it appears that the homo-
transplantation antigen is definitely involved in the immunological control
of tumor development.'
Although not constituting direct proof, nevertheless, the persistence of
these antigens and especially their specificity is strong evidence for the
continued presence of the genome of the original inducing virus even in
the now "virus-free" tumors. Thus, studies on antigen confirm other
evidence for the persistence of viral genetic material in cells they transform
even though infectious virus cannot be demonstrated.
Perhaps one of the most significant facts concerning these antigens is that
they introduce something previously sadly lacking in the tumor virus field
-namely, specificity. In spite of the possible pitfalls and problems in their
application, the evidence for etiological relationship of a given tumor with
a given virus which the demonstration of these antigens makes possible will
give sharper focus to many future tumor virus studies.
Since the homotransplantation type of virus-induced antigen appears to
be responsible for suppression of tumor growth under certain conditions in
immunologically competent animals, there are now two possible specific
ways in which susceptible animals may be protected from the development
of a virus-induced tumor. First, the individual might be protected from
successful infection with the virus by use of anti-viral vaccines or passive
antiviral antisera, and secondly, by immunization with the new specific
tumor antigen to enhance the ability to reject any developing virus tumor
by a homograft type of reaction. Such protective measures would, of course,
be ineffective if virus transmission were vertical from the mother to the
fetus with subsequent immunological tolerance to both the viral and tumor
antigens. However, some interesting experiments have already suggested
possible application of these hypothetical procedures. Newborn hamsters
inoculated with a dose of SV 40 virus which regularly produces tumors
after a long latent period will fail to develop tumors if inoculated as young
adults with repeated doses of either SV 40 virus' or irradiated SV 40
hamster tumor cells.'
Another interesting but somewhat frightening development in viral
oncology is also related to the presence of new cellular antigens in virus-
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transformed cells. It has been found that the species specificity of certain
tumor viruses is not nearly as strict as once assumed. Polyoma, a natural
virus of mice, can produce tumors in a number of rodents; SV 40, a monkey
virus, can produce tumors in mice and hamsters and transform human cells
in vitro;' the Rous sarcoma virus, an avian tumor virus, has been shown
capable of inducing tumors in rats,' hamsters,' mice," guinea pigs,"
rabbits,Ta and even monkeys.'4 Furthermore, there is evidence of in vitro
transformation of human cells by this chicken virus.' For these viruses to
produce tumors in foreign species requires the elimination or diminution
of the immunological competence of the host. This would suggest that many,
if not all. tumor viruses have the inherent capability under the proper set
of conditions of transforming cells of divergent species but that they are
unlikely to induce tumors in these species under natural conditions of infec-
tion because immunological rejection of the transformed cells prevents their
multiplication to form a gross tumor.
IMMUNOLOGICAL IMPLICATIONS FOR THE EPIDEMIOLOGY OF VIRUS-INDUCED
TUMORS
That tumor viruses are maintained in nature through successive infection
cycles in the same way as viruses causing acute disease is now apparent.
Although possible vertical transmission through the germ cells or by intra-
uterine infection offer special epidemiological stituations for some tumor
viruses, in the case of others the individual is infected by contact. Thus
many laboratory mouse colonies' as well as wild mice" are known to be
highly infected with polyoma virus due to excretion of the virus in the
urine and feces of those infected. Yet in spite of the high rate of infection,
the appearance of a polyoma-induced tumor is apparently an extreme rarity.
A logical explanation invokes the suppressive effect of immunological
rejection of early developing tumor cells due to their "foreign" antigen.
Perhaps the only way a polyoma tumor can be induced under natural
conditions of infection is the rare combination of a large infecting dose of
virus introduced into an immunologically incompetent newborn and/or the
subsequent occurrence of an event decreasing the immunological capability
of the young adult.
If there is an infectious tumor virus of man, then all our-epidemiological
experience with acute disease viruses would suggest that the individuals
developing gross tumors are not the only ones infected. Such viruses would
probably be ubiquitous with large proportions of the population infected.
Just as in other virus diseases, such as poliomyelitis, both viral and host
factors would determine which individual develops the full clinical mani-
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festations of the infection. Studies on experimental virus tumors suggest
that immunological competence may be an important one of these host
factors.
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DISCUSSION: FRANCIS L. BLACK*
I wish Dr. Francisco Duran-Reynals could be here today to hear
Dr. Habel's presentation. For 20 years Dr. Duran-Reynals worked here at
Yale to try to convince the world of the significance of viruses in the
etiology of cancer. Few listened, and at the time his work must have seemed
unappreciated; but through those few listeners his labors have borne much
fruit. I am sure he would take great pleasure today in seeing the point to
which the knowledge of tumor viruses has advanced. In particular,
Dr. Habel's important studies on the immunological factors in viral
oncogenicity form a fitting sequel to Dr. Duran-Reynals' studies on Rous
sarcoma.1
Dr. Habel has pointed out the epidemiological significance of immune
reactions to tumor antigens: the special susceptibility of the young, immuno-
logically immature animal means that we must look for the initial infection
in very early life, quite possibly, as in rubella, long before birth.
There are other epidemiological implications in this presentation that
deserve attention. Polyoma virus acquired its name from the fact that
it may cause a wide variety of tumors in various organs. If we are to look
for patterns of viral carcinogenesis in man, we must be alert to patterns that
cross the conventional classifications of tumors. Polyoma, in high titer, will
cause death within a few days, sometimes due to kidney tumors and, under
other circumstances, to hemorrhages in the liver caused by minute endo-
theliomas. In lower titer, polyoma usually causes relatively benign tumors
at the site of injection that become recognizable only in adult life and may
then grow to enormous size before causing death. The suggestion that
Burkitt's lymphoma of the jaw and childhood leukemia may have a common
etiology is in line with the concept of multiple forms of cancer with a single
primary cause. We must be alert to other such interrelationships between
histologically diverse tumors. The common classification of cancer by site
may be quite inadequate for epidemiological analysis.
*Associate Professor of Epidemiology and Public Health, Yale University School
of Medicine.
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